pathway
Important new treatment for the most common skin cancer (basal cell carcinoma) called Erivedge (vismodegib)
The FDA approved a novel new treatment for the most common kind of skin cancer. The drug is called Erivedge (vismodegib) and treats patients with basal cell carcinoma.
Approval Date:
Mon, 01/30/2012
Company:
Genentech/Roche


